MCCCD Program Description

Introduction and Overview of Cancer Disease

Course: NCE101

First Term: 2013 Spring

Lecture 2.0 Credit(s) 2.0 Period(s) 2.0 Load
Subject Type: Occupational
Load Formula: S

Description: Introduction and overview of the disease and treatment of cancer including cancer origin, development, pathology, staging, hematopoiesis, epidemiology, diagnosis modalities, treatment options, cancer research and differentiation of solid tumors versus nonsolid tumors. Effective analysis, synthesis, and evaluation of topics through written discourse.

MCCCD Official Course Competencies
1. Describe cancer`s origin and development. (I) 2. Contrast and differentiate staging versus grading in cancer. (I) 3. Describe the role of the tumor registrar and the pathologist. (I) 4. Discuss the epidemiology, diagnosis, staging and treatment of specific cancers. (II) 5. Describe the process of hematopoiesis by listing the progenitor cells and their offspring. (III) 6. Define the difference between humoral and cell-mediated immunity. (III) 7. Compare acute and chronic types of leukemia. (III) 8. Compare Hodgkin`s Lymphoma with Non-Hodgkin`s Lymphoma. (III) 9. Describe the stages and drug development process of cancer research. (IV) 10. Describe three structural and three metabolic emergencies in oncology and their treatment options. (V)
MCCCD Official Course Competencies must be coordinated with the content outline so that each major point in the outline serves one or more competencies. MCCCD faculty retains authority in determining the pedagogical approach, methodology, content sequencing, and assessment metrics for student work. Please see individual course syllabi for additional information, including specific course requirements.

MCCCD Official Course Outline
I. Basics of Oncology/Cancer A. Cancer epidemiology and characteristics B. Types of staging and techniques C. Detection/diagnostic methods D. Treatment options II. Types of Cancer A. Lung B. Breast C. Colon D. Prostate E. Gynecologic F. Head and Neck G. Testicular III. Hematopoiesis A. Normal Hematopoiesis B. Normal Immune system C. Hematologic Malignancies IV. Cancer Research A. National Institutes of Health/National Cancer Institute/Cooperative Group Trials B. Basic, Translational and Clinical Research C. Drug, Biologic, Device Research V. Oncologic Emergencies A. Superior Vena Cava Syndrome (SVC) Syndrome B. Tumor Lysis Syndrome C. Spinal Cord Compression D. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) E. Sepsis F. Hypercalcemia

MCCCD Governing Board Approval Date: 12/11/2012

All information published is subject to change without notice. Every effort has been made to ensure the accuracy of information presented, but based on the dynamic nature of the curricular process, course and program information is subject to change in order to reflect the most current information available.